Features

  • Non-pharmacological Interventions for VMS - 11.00 PM AEST 16 April 2024
      Moderator: Professor Peter Schnatz Speakers: Professor Myra Hunter: ‘Cognitive Behavioural Therapy (CBT)’ Professor Gary Elkins: ‘Hypnosis’ Date and Time: Apr 16, 2024 11:00 PM AEST As this webinar is late, it may not be convenient for you to attend. The recorded webinar will be available on the IMS... Members Login to Read more...
  • eChanges March 2024
    Inside this issue  AMS News President's Editorial Testosterone use in women The Lancet series on Menopause Menopausal Hormone Therapy (MHT) discontinuation and shortages March 2024 Menopause Down Under, Sydney | Saturday 6 April 2024 IMS World Congress on Menopause in Melbourne 2024 News from... Members Login to Read more...
  • Lancet series on Menopause 2024
    The Lancet has published a series on menopause which cautions against the ‘over medicalisation’ of menopause, and calls for an empowerment model. AMS agrees that we need to empower women to manage their menopause transition, their post-menopausal health and well-being, and indeed has been... Read more...
  • eChanges February 2024
    Inside this issue  AMS News President's Report Cognitive Decline Menopausal Hormone Therapy (MHT) discontinuation and shortages February 2024 AMS Webinar: Vasomotor symptom (VMS) management with non-hormonal options Menopause Down Under, Sydney | Saturday 6 April 2024 IMS World Congress on... Members Login to Read more...
  • eChanges January 2024
    Inside this issue  AMS News President's Report Updated AMS Information Sheet: Bleeding – perimenopausal, postmenopausal and breakthrough bleeding on MHT/HRT Menopausal Hormone Therapy (MHT) discontinuation and shortages January 2024 IMS World Congress on Menopause in Melbourne 2024 News from Around the... Members Login to Read more...
  • Sexually Transmitted Infections in Midlife Women
    According to the Centers for Disease Control and Prevention (CDC), rates of sexually transmitted infections (STIs) are increasing in all age groups. And, contrary to the common assumption that older women are not sexually active or are in mutually monogamous relationships, a high proportion of... Members Login to Read more...
  • How do we best support women in the workplace as they transition through menopause?
    By Dr Marita Long Women can experience a range of symptoms as they transition through the menopause years and some of these can have a significant impact on their attendance and performance in the workplace. This has given rise to considerable discussion and debate around how we can best support... Members Login to Read more...
  • eChanges December 2023
    Inside this issue  AMS News President's Report How do we best support women in the workplace as they transition through menopause? Menopausal Hormone Therapy (MHT) Patch discontinuation and shortages Seasons Greetings IMS World Congress on Menopause in Melbourne 2024 News from Around the World... Members Login to Read more...
  • Neurodiverse Women and Menopause
    By Dr Carmel Reynolds There has been a relatively recent increase in community awareness of neurodivergence in women, and this has had a significant flow on effect in the numbers of women presenting for assessment. I am sure that most practitioners working in primary care and mental health fields... Members Login to Read more...
  • eChanges November 2023
    Inside this issue  AMS News President's Report Neurodiverse Women and Menopause Senate Inquiry into issues relating to menopause and perimenopause Menopausal Hormone Therapy (MHT) Patch discontinuation and shortages IMS - A Special Membership Offer for Members of the Australasian Menopause Society IMS... Members Login to Read more...
  • A Practitioner’s Toolkit for the Management of the Menopause
    Developed by the Women’s Health Research Program in the Monash University School of Public Health and Preventive Medicine, 2023.The supporting notes for the Practitioner’s Toolkit for Managing Menopause are published, with free access, in Climacteric, the journal of the International Menopause... Read more...
  • Management of menopause
    By Dr Karen Magraith and Dr Christina Jang:  Menopausal hormone therapy is the most effective treatment for menopausal symptoms and, for most women, the benefits of symptom control outweigh the potential harms of therapy. The article is available free online from the Australian Prescriber, Issue 3... Read more...
  • IMS White Paper – Reproductive milestones across the lifespan and cardiovascular disease risk in women
    Cardiovascular disease (CVD) is the leading cause of death for women across the developed and developing world. Beyond traditional cardiovascular risk factors, a number of reproductive milestones have been recognized. The goal of this White Paper, issued by the International Menopause Society in... Read more...
  • eChanges September 2023
    Inside this issue  AMS News President's Report Updated AMS Information Sheet: Tibolone as menopausal hormone therapy 26th Annual Australasian Menopause Society Congress Synopsis New AMS Board Director: Dr Amie Hanlon AMS Congress Award and Prize Winners AMS Scholarship – Ms Celine Camon Menopause... Members Login to Read more...
  • Menopause Essentials Update 2023
    Saturday 4 November -  12.00-4.30pm  Join us for lunch followed by an update on the essentials of menopause management. This workshop is aimed at GPs, gynaecologists, endocrinologists and other health professionals who are seeking a comprehensive review of the current issues that face them in the... Read more...
  • FRAXplus®: Refining risk prediction
    Accurate assessment of fracture risk is essential for optimal diagnosis and management of osteoporosis.The FRAX® fracture risk assessment tool has substantially improved the identification of people at high risk of fracture since its launch in 2008. To date, 86 FRAX models have been made available... Members Login to Read more...
  • Primary Ovarian Insufficiency
    Loss of ovarian follicular activity (spontaneous or induced) before the age of 40 years constitutes primary ovarian insufficiency. It is characterized by hypergonadotropic hypogonadism (low estradiol and elevated gonadotropin levels) and results in loss of fertility and premature deficiency of... Members Login to Read more...
  • eChanges August 2023
    Inside this issue  AMS News President's Report Baseline (knowledge) and Basis (evidence) for Menopause Management New courses on AMS eLearning – Free for AMS members! Menopausal hormone therapy (MHT) patch shortages 26th AMS Congress, Queenstown, New Zealand, 1-3 September 2023 IMS World Congress on... Members Login to Read more...
  • Personalized oral combined MHT and long-term effects: How to choose according to the patient’s needs Webinar
    Date:  27 March 2024 Time: 14.00 CET (Paris time) | 12.00 am AEST 28 March 2024  Chair Prof. Tim Hillard, UK Speakers  Dr Larysa Mishchenko, Ukraine Dr Suvarna Khadilkar, India   The webinar will be recorded and you will be notified of the recording if you register to attend. Members Login to Read more...
  • Menopause in the Workplace after COVID Webinar
    Date:  7 September 2023 Time: 4.00 p.m. CET (Paris time) | 12.00 am AEST 8 September 2023  Speakers     The webinar will be recorded and you will be notified of the recording if you register to attend. Members Login to Read more...

Print